Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures

Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures

Bisphosphonates (BPs) are administered to Multiple Myeloma (MM) patients with bone lytic lesion. Osteonecrosis of the Jaw (ONJ) is a complication reported since 2003 in patients treated with intravenous (IV) BPs such as zoledronic acid and pamidronate, with 6%–26.3% frequency in early literature se...

Full description

Bibliographic Details
Main Authors: Gioacchino Catania, Federico Monaco, Giulia Limberti, Manuela Alessio, Iolanda De Martino, Cecilia Barile, Antonella Fasciolo, Anna Baraldi, Marco Ladetto, Vittorio Fusco
Format: Article
Language:English
Published: MDPI AG 2016-12-01
Series:Dentistry Journal
Subjects:
Bisphosphonate
pamidronate
zoledronic acid
Multiple Myeloma
Osteonecrosis of the Jaws
BRONJ
MRONJ
prevention
Online Access:http://www.mdpi.com/2304-6767/4/4/45

Internet

http://www.mdpi.com/2304-6767/4/4/45

Similar Items